These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23553437)

  • 1. Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
    Natoli A; Lüpertz R; Merz C; Müller WW; Köhler R; Krammer PH; Li-Weber M
    Int J Cancer; 2013 Oct; 133(8):1945-54. PubMed ID: 23553437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Patterson B; Trumper L; Kapp U; Mak TW
    Blood; 2002 Jan; 99(2):618-26. PubMed ID: 11781246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of an IL-13 autocrine growth loop in a human Hodgkin/Reed-Sternberg tumor cell line by a novel IL-13 antagonist.
    Oshima Y; Puri RK
    Cell Immunol; 2001 Jul; 211(1):37-42. PubMed ID: 11585386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin induces cell-arrest and apoptosis in association with the inhibition of constitutively active NF-kappaB and STAT3 pathways in Hodgkin's lymphoma cells.
    Mackenzie GG; Queisser N; Wolfson ML; Fraga CG; Adamo AM; Oteiza PI
    Int J Cancer; 2008 Jul; 123(1):56-65. PubMed ID: 18386790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
    Baus D; Nonnenmacher F; Jankowski S; Döring C; Bräutigam C; Frank M; Hansmann ML; Pfitzner E
    Leukemia; 2009 Oct; 23(10):1885-93. PubMed ID: 19440213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 13: a growth factor in hodgkin lymphoma.
    Skinnider BF; Kapp U; Mak TW
    Int Arch Allergy Immunol; 2001 Dec; 126(4):267-76. PubMed ID: 11815733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma.
    Cattaruzza L; Gloghini A; Olivo K; Di Francia R; Lorenzon D; De Filippi R; Carbone A; Colombatti A; Pinto A; Aldinucci D
    Int J Cancer; 2009 Sep; 125(5):1092-101. PubMed ID: 19391137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL.
    Wurster AL; Rodgers VL; White MF; Rothstein TL; Grusby MJ
    J Biol Chem; 2002 Jul; 277(30):27169-75. PubMed ID: 12023955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells.
    Stanelle J; Döring C; Hansmann ML; Küppers R
    Blood; 2010 Nov; 116(20):4202-11. PubMed ID: 20660789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G; Chang BS; Kim CN; Perkins C; Thompson CB; Bhalla KN
    Cancer Res; 1998 Aug; 58(15):3202-8. PubMed ID: 9699642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of interleukin 13 in classical Hodgkin lymphoma.
    Skinnider BF; Kapp U; Mak TW
    Leuk Lymphoma; 2002 Jun; 43(6):1203-10. PubMed ID: 12152987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4-mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways.
    Wang J; Hu Y; Nekvindova J; Ingelman-Sundberg M; Neve EP
    Biochem Pharmacol; 2010 Nov; 80(10):1592-600. PubMed ID: 20723539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic and transcriptional control of the 15-lipoxygenase-1 gene in a Hodgkin lymphoma cell line.
    Liu C; Schain F; Han H; Xu D; Andersson-Sand H; Forsell P; Claesson HE; Björkholm M; Sjöberg J
    Exp Cell Res; 2012 Feb; 318(3):169-76. PubMed ID: 22094113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth.
    Guruprasath P; Kim J; Gunassekaran GR; Chi L; Kim S; Park RW; Kim SH; Baek MC; Bae SM; Kim SY; Kim DK; Park IK; Kim WJ; Lee B
    Biomaterials; 2017 Oct; 142():101-111. PubMed ID: 28732245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 protects the B-cell lymphoma cell line CH31 from anti-IgM-induced growth arrest and apoptosis: contribution of the PI-3 kinase/AKT pathway.
    Carey GB; Semenova E; Qi X; Keegan AD
    Cell Res; 2007 Nov; 17(11):942-55. PubMed ID: 17968425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
    Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
    Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented efficacy of brentuximab vedotin combined with ruxolitinib and/or Navitoclax in a murine model of human Hodgkin's lymphoma.
    Ju W; Zhang M; Wilson KM; Petrus MN; Bamford RN; Zhang X; Guha R; Ferrer M; Thomas CJ; Waldmann TA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1624-9. PubMed ID: 26811457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
    Skinnider BF; Elia AJ; Gascoyne RD; Trümper LH; von Bonin F; Kapp U; Patterson B; Snow BE; Mak TW
    Blood; 2001 Jan; 97(1):250-5. PubMed ID: 11133768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin's lymphoma cells.
    Li ZM; Jiang WQ; Zhu ZY; Zhu XF; Zhou JM; Liu ZC; Yang DJ; Guang ZZ
    Cancer Biol Ther; 2008 Jan; 7(1):51-60. PubMed ID: 17938578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor BLU promotes paclitaxel antitumor activity by inducing apoptosis through the down-regulation of Bcl-2 expression in tumorigenesis.
    Park ST; Byun HJ; Kim BR; Dong SM; Park SH; Jang PR; Rho SB
    Biochem Biophys Res Commun; 2013 May; 435(1):153-9. PubMed ID: 23628417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.